Prevalence of Thyroiditis Following Either COVID-19 Infection or Vaccination in a Group of Egyptian Hashimoto Cases

Abstract Background Hashimoto's thyroiditis (HT), the most frequent autoimmune thyroid disorders (AITDs), is the leading cause of hypothyroidism in the iodine-sufficient areas of the world. COVID-19 is a highly transmissible infectious disease caused by the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV- 2), belong to the family of beta-coronaviruses. The disease rapidly spread, leading to COVID-19 pandemic on March 11, 2020. Aim of the Work The aim of this study was to evaluate the thyroid function consequences following either (COVID-19) infection or vaccination, in relation to their clinical features, biochemical, immunological, and inflammatory markers. Patients and Methods This study was a pilot study, conducted on 80 subjects attending COVID vaccination center and Emergency isolation in Ain Shams university hospital during the period from August to October 2022 14 males, 66 females, age>18 years old and <70 years’ old to evaluate the thyroid function consequences following either (COVID-19) infection or vaccination, in relation to their clinical features, biochemical, immunological, and inflammatory markers. Results Our study showed significant increase in the level of TSH and decrease in the level of free T3, Free T4 in Hashimoto’s patients who exposed to COVID19 infection. Also it showed significant increase in the level of free T3, Free T4 and decrease level of TSH in normal subjects after exposure to COVID19 infection. Additionally, our study showed increase level of free T3, Free T4 in normal subjects after being exposed to COVID19 vaccine (AstraZeneca) in contrast to TSH being decreased in them. Furthermore, we found significant increase in the level of free T3, Free T4 in Hashimoto’s subjects after their exposure to AstraZeneca vaccine, with non significant difference regarding –anti- TPO, Antithyroglobulin. Conclusion COVID19 infection and vaccination against COVID might be followed by an attack of thyroiditis (disturbed thyroid function test) in Hashimoto patient and even in normal person.

Authors

Institutions

Publication Details

Journal
QJM
Published
2024-10-01
DOI
https://doi.org/10.1093/qjmed/hcae175.421
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Thyroiditis Following Either COVID-19 Infection or Vaccination in a Group of Egyptian Hashimoto Cases

Hany Khairy Mansour, Laila Mahmoud Ali Hendawy, Menna Allah Adel Mohammed, Khaled Mahmoud Makboul
QJM
Thyroid Disorders and Treatments
article

Prevalence of Thyroiditis Following Either COVID-19 Infection or Vaccination in a Group of Egyptian Hashimoto Cases

Hany Khairy Mansour, Laila Mahmoud Ali Hendawy, Menna Allah Adel Mohammed, Khaled Mahmoud Makboul
article en

Abstract

Abstract Background Hashimoto's thyroiditis (HT), the most frequent autoimmune thyroid disorders (AITDs), is the leading cause of hypothyroidism in the iodine-sufficient areas of the world. COVID-19 is a highly transmissible infectious disease caused by the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV- 2), belong to the family of beta-coronaviruses. The disease rapidly spread, leading to COVID-19 pandemic on March 11, 2020. Aim of the Work The aim of this study was to evaluate the thyroid function consequences following either (COVID-19) infection or vaccination, in relation to their clinical features, biochemical, immunological, and inflammatory markers. Patients and Methods This study was a pilot study, conducted on 80 subjects attending COVID vaccination center and Emergency isolation in Ain Shams university hospital during the period from August to October 2022 14 males, 66 females, age>18 years old and <70 years’ old to evaluate the thyroid function consequences following either (COVID-19) infection or vaccination, in relation to their clinical features, biochemical, immunological, and inflammatory markers. Results Our study showed significant increase in the level of TSH and decrease in the level of free T3, Free T4 in Hashimoto’s patients who exposed to COVID19 infection. Also it showed significant increase in the level of free T3, Free T4 and decrease level of TSH in normal subjects after exposure to COVID19 infection. Additionally, our study showed increase level of free T3, Free T4 in normal subjects after being exposed to COVID19 vaccine (AstraZeneca) in contrast to TSH being decreased in them. Furthermore, we found significant increase in the level of free T3, Free T4 in Hashimoto’s subjects after their exposure to AstraZeneca vaccine, with non significant difference regarding –anti- TPO, Antithyroglobulin. Conclusion COVID19 infection and vaccination against COVID might be followed by an attack of thyroiditis (disturbed thyroid function test) in Hashimoto patient and even in normal person.

QJMVol. 117(Supplement_2)
Ain Shams University (EG)
Openalex Percentile: Top 67%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prevalence of Thyroiditis Following Either COVID-19 Infection or Vaccination in a Group of Egyptian Hashimoto Cases — Hany Khairy Mansour, Laila Mahmoud Ali Hendawy, et al. · QJM (2024) | TGRS Research Map | TGRS